Anderson K C KC

Show results for

Unknown (379)
Genomics (8)
Transcriptomics (4)
Proteomics (4)

Organisms

Homo sapiens (12)
Alphavirus (3)
Anemia (3)
Betaherpesvirinae (3)
Brassica oleracea var. oleracea (3)
Cowpox virus (3)
Coxsackievirus (3)
Cytomegalovirus (3)
Dengue virus (3)
EFO:0001352 (3)
Filoviridae (3)
Hepatitis B virus (3)
Human alphaherpesvirus 1 (3)
Human betaherpesvirus 5 (3)
Human immunodeficiency virus (3)
Human immunodeficiency virus 1 (3)
Human immunodeficiency virus 2 (3)
Influenza A virus (3)
Influenza C virus (3)
Japanese encephalitis virus group (3)
Lyssavirus rabies (3)
Monkeypox virus (3)
Nostoc sp. PCC 7120 = FACHB-418 (3)
Oropouche virus (3)
Orthopoxvirus (3)
Orthopoxvirus vaccinia (3)
Rattus (3)
Staphylococcus aureus (3)
Tick-borne encephalitis virus (3)
Viruses (3)

Repository

EGA (8)
biostudies-arrayexpress (4)
pride (3)
MassIVE (1)

Tissue

Blood (1)
Blood cell (1)
Cell culture (1)
Multiple myeloma cell line (1)
Permanent cell line cell (1)
Plasma cell (1)

Disease

Malaria (1)
Multiple myeloma (1)
Non-small cell lung carcinoma (1)

Technology Type

Mass Spectrometry (3)
Illumina Genome Analyzer II, Illumina HiSeq 2000 (1)
Affinity purification coupled with mass spectrometry proteomics (1)
Bottom-up proteomics (1)
Data-dependent acquisition (1)
Gel-based experiment (1)
SWATH MS (1)
Shotgun proteomics (1)

Instrument Platform

Orbitrap Fusion Lumos (1)

Publication Date

2009 (2)
2012 (1)
2011 (1)
2021 (1)
2025 (1)
2023 (1)
2022 (1)

Study type

Transcription profiling by array (3)
Comparative genomic hybridization by array (1)

Release Date

2018 (43)
2020 (38)
2021 (33)
2023 (30)
2022 (28)
2025 (26)
2024 (26)
2015 (26)
2012 (22)
2013 (17)
2009 (14)
2016 (14)
2019 (13)
2017 (13)
2014 (12)
2011 (10)
2008 (6)
2010 (5)
2026 (4)
2007 (3)

Lab affiliation

Department of Medical Oncology, Dana-Farber Cancer Institute (1)
Department of Pharmacology and Cancer Biology Duke University School of Medicine Durham, North Carolina (1)
Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia (1)

Previous page
1 / 40
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 40
Next page

Sort by:

Relevance

Page size

JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells.

Not available

S-EPMC1924477 | biostudies-literature

Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myeloma.

Not available

S-EPMC4874204 | biostudies-literature

LncPRESS1 Is a p53-Regulated LncRNA that Safeguards Pluripotency by Disrupting SIRT6-Mediated De-acetylation of Histone H3K56.

Not available

S-EPMC5137794 | biostudies-literature

Alternations in inflammatory macrophage niche drive phenotypic and functional plasticity of Kupffer cells.

Not available

S-EPMC11522483 | biostudies-literature

Huma Multiple Myeloma Cell line, AMO1, treated with NCP26, LC-MSMS analysis

The human multiple myeloma cell line, AMO1, was treated with NCP26, an ATP-competitive EPRS inhibitor, and a total proteome-wide analysis was performed to determine the effect of NCP26 treatment on protein dynamics.

ORGANISM(S): Homo sapiens (Human)

2023-03-11 | PXD029453 | Pride